Evidence map›Paper›PMID 20668433›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2011

Modes and models of forebrain cholinergic neuromodulation of cognition.

Michael E Hasselmo, Martin Sarter

Open access · bronzeAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 417 papers.

0numbers the graph read from it
0cells of the map it votes in
417citing papers in PubMed
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

417 citing papers in PubMed, 726 citations in OpenAlex.

  1. Trial
  2. Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Differential and state-dependent effects of the GluN2A-selective positive allosteric modulator GNE-5729 on executive functions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Spatially structured heterogeneity shapes large-scale cortical dynamics in a model of the human cortex.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

357 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael E HasselmoCenter for Memory and Brain, Department of Psychology, Boston University, Boston, MA 02215, USA. hasselmo@bu.edu
Martin Sarter
Boston University · USUniversity of Michigan–Ann Arbor · US

Funding

Models of behavior and spike timing in sequence memoryP50MH071702 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI EICHENBAUM, HOWARD B. · 2006 to 2010
$8.8M
NEUROMODULATION AND CORTICAL MEMORY FUNCTIONR01MH060013 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HASSELMO, MICHAEL E · 2000 to 2019
$6.8M
Mechanisms of Entorhinal Cortex FunctionR01MH061492 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HASSELMO, MICHAEL E · 2000 to 2017
$5.0M
Choline transporter capacity limits motivated behavior on mice, rats, and humansR01MH086530 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2010 to 2014
$1.9M
Nicotinic regulation of cortical ACh release and behavioral functionR01MH080332 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2007 to 2010
$1.2M
In vivo screening of cholinergic cognition enhancersR21MH080426 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2007 to 2008
$367k
NIMH NIH HHS MH71702NIMH NIH HHS P50 MH071702NIMH NIH HHS R01 MH060013NIMH NIH HHS R01 MH061492NIMH NIH HHS R01 MH080332NIMH NIH HHS R01 MH086530NIMH NIH HHS R01 MH60013NIMH NIH HHS R01 MH61492NIMH NIH HHS R21 MH080426
6 · The paper itself

Abstract

As indicated by the profound cognitive impairments caused by cholinergic receptor antagonists, cholinergic neurotransmission has a vital role in cognitive function, specifically attention and memory encoding. Abnormally regulated cholinergic neurotransmission has been hypothesized to contribute to the cognitive symptoms of neuropsychiatric disorders. Loss of cholinergic neurons enhances the severity of the symptoms of dementia. Cholinergic receptor agonists and acetylcholinesterase inhibitors have been investigated for the treatment of cognitive dysfunction. Evidence from experiments using new techniques for measuring rapid changes in cholinergic neurotransmission provides a novel perspective on the cholinergic regulation of cognitive processes. This evidence indicates that changes in cholinergic modulation on a timescale of seconds is triggered by sensory input cues and serves to facilitate cue detection and attentional performance. Furthermore, the evidence indicates cholinergic induction of evoked intrinsic, persistent spiking mechanisms for active maintenance of sensory input, and planned responses. Models have been developed to describe the neuronal mechanisms underlying the transient modulation of cortical target circuits by cholinergic activity. These models postulate specific locations and roles of nicotinic and muscarinic acetylcholine receptors and that cholinergic neurotransmission is controlled in part by (cortical) target circuits. The available evidence and these models point to new principles governing the development of the next generation of cholinergic treatments for cognitive disorders.

Indexed as

Models, NeurologicalAcetylcholineAction PotentialsAnimalsAttentionCholinergic FibersCognitionHumansNeural PathwaysNeuronsPerceptionProsencephalonAcetylcholine

Identifiers

PMID20668433
PMCPMC2992803
OpenAlexW2036322060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.